Corcept Therapeutics Incorporated
CORT
$57.08
$5.9211.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 47.34M | 99.65M | 106.11M | 133.66M | 133.99M |
| Total Depreciation and Amortization | 2.03M | 1.89M | 1.87M | 1.89M | 1.62M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.53M | 41.86M | 48.11M | 15.16M | 13.43M |
| Change in Net Operating Assets | 26.20M | -1.76M | 7.16M | 31.36M | 30.27M |
| Cash from Operations | 120.10M | 141.64M | 163.25M | 182.06M | 179.31M |
| Capital Expenditure | -308.00K | -211.00K | -282.00K | -1.92M | -2.28M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 77.78M | 69.97M | 17.52M | -39.52M | -169.49M |
| Cash from Investing | 77.47M | 69.76M | 17.24M | -41.44M | -171.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28.56M | 25.49M | 22.59M | 20.66M | 11.38M |
| Repurchase of Common Stock | -208.36M | -245.86M | -216.30M | -189.05M | -78.99M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -179.80M | -220.37M | -193.71M | -168.39M | -67.61M |
| Foreign Exchange rate Adjustments | 1.16M | 1.80M | 1.07M | 1.93M | 130.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 18.92M | -7.17M | -12.15M | -25.84M | -59.93M |